PatientsVille.com Logo

Mucosta Side Effects

PatientsVille

Common Mucosta Side Effects


The most commonly reported Mucosta side effects (click to view or check a box to report):

Pyrexia (15)
Liver Disorder (11)
Decreased Appetite (11)
Interstitial Lung Disease (9)
Shock (7)
Hepatic Function Abnormal (6)
Cerebral Haemorrhage (6)
Anaemia (6)
Abdominal Pain (5)
Ascites (5)
Death (5)
Nausea (4)
Multi-organ Failure (4)
Lung Disorder (4)
Oedema (4)
Rash (4)
White Blood Cell Count Increased (4)
Thrombocytopenia (4)
Septic Shock (4)
Platelet Count Decreased (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Mucosta Side Effects Reported to FDA



Mucosta Side Effect Report#9604422
Blood Fibrinogen Decreased
This is a report of a 26-year-old male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: NA, who was treated with Mucosta (dosage: NA, start time:
Sep 03, 2013), combined with:
  • Trisenox (.15 Milligram Daily;)
  • Trisenox
  • Trisenox
  • Trisenox
  • Trisenox
  • Bio-three
and developed a serious reaction and side effect(s): Blood Fibrinogen Decreased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosta treatment in male patients, resulting in Blood Fibrinogen Decreased side effect. The patient was hospitalized.
Mucosta Side Effect Report#8477982-4
Depression
This report suggests a potential Mucosta Death side effect(s) that can have serious consequences. A female patient (weight: NA) from Denmark was diagnosed with the following symptoms/conditions: gastritis,insomnia,depression,sleep disorder,initial insomnia and used Mucosta (dosage: 200 Mg) starting
Apr 04, 2012. After starting Mucosta the patient began experiencing various side effects, including: DepressionAdditional drugs used concurrently:
  • Goodmin (0.25 Mg)
  • Lexapro (10 Mg)
  • Medipeace (1 Mg)
  • Amoban (7.5 Mg)
Although Mucosta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Death, may still occur.
Mucosta Side Effect Report#8476585-5
Depression
This Death problem was reported by a health professional from Denmark. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: gastritis,initial insomnia,depression,sleep disorder. On
Feb 09, 2012 this consumer started treatment with Mucosta (dosage: 200 Mg). The following drugs were being taken at the same time:
  • Amoban (7.5 Mg)
  • Lexapro (10 Mg)
  • Medipeace (1 Mg)
  • Goodmin (0.25 Mg)
When using Mucosta, the patient experienced the following unwanted symptoms/side effects: DepressionAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.
Mucosta Side Effect Report#8476381-9
Lung Disorder
This Lung Disorder side effect was reported by a physician from Japan. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Mucosta (drug dosage: 300 Mg), which was initiated on
Oct 23, 2011. Concurrently used drugs:
  • Lipitor (20 Mg)
  • Pradaxa (220 Mg)
  • Micardis (40 Mg)
  • Platibit
.After starting to take Mucosta the consumer reported adverse symptoms, such as: Lung DisorderThese side effects may potentially be related to Mucosta. The patient was hospitalized.
Mucosta Side Effect Report#8462537-8
Rash
This is a report of a 68-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Mucosta (dosage: NA, start time:
Mar 05, 2012), combined with:
  • Peginterferon Alfa-2b
  • Allopurinol
  • Peginterferon Alfa-2b
  • Ribavirin
  • Telavic (telaprevir)
  • Evamyl
and developed a serious reaction and side effect(s): Rash after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosta treatment in female patients, resulting in Rash side effect.
Mucosta Side Effect Report#8461827-2
Henoch-schonlein Purpura Nephritis, Henoch-schonlein Purpura
This report suggests a potential Mucosta Henoch-schonlein Purpura Nephritis side effect(s) that can have serious consequences. A 67-year-old female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: gastritis prophylaxis,rheumatoid arthritis,osteoporosis,hyperuricaemia,neuralgia,constipation and used Mucosta (dosage: 100 Mg, 3x/day) starting
Feb 28, 2012. After starting Mucosta the patient began experiencing various side effects, including: Henoch-schonlein Purpura Nephritis, Henoch-schonlein PurpuraAdditional drugs used concurrently:
  • Enbrel (50 Mg, Weekly)
  • One-alpha (1 Ug, 1x/day)
  • Allopurinol (100 Mg, 1x/day)
  • Lyrica (75 Mg, 1x/day)
  • Magmitt (500 Mg, 3x/day)
  • Zantac (150 Mg, 1x/day)
  • Diovan (80 Mg, 1x/day)
  • Hokunalin /00654902/ (2 Mg, 2x/day)
The patient was hospitalized. Although Mucosta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Henoch-schonlein Purpura Nephritis, may still occur.
Mucosta Side Effect Report#8459844-1
Papule, Lymphadenopathy, White Blood Cell Count Increased, Oedema, Lymphocytic Infiltration, Epidermal Necrosis, Liver Disorder, Pyrexia
This Papule problem was reported by a health professional from Japan. A 59-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: sciatica. On
Jun 15, 2011 this consumer started treatment with Mucosta (dosage: NA). The following drugs were being taken at the same time:
  • Vitamin B12
  • Neurotropin
  • Tokishigyakukagoshuyushokyoto
  • Rinlaxer
  • Opalmon
  • Syakuyakukanzoto
  • Tegretol (200 Mg, Daily)
  • Voltaren (25 Mg, Daily)
When using Mucosta, the patient experienced the following unwanted symptoms/side effects: Papule, Lymphadenopathy, White Blood Cell Count Increased, Oedema, Lymphocytic Infiltration, Epidermal Necrosis, Liver Disorder, PyrexiaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Papule, may become evident only after a product is in use by the general population.
Mucosta Side Effect Report#8451017-1
Neuropathy Peripheral, Cardiac Failure Congestive, Cardiomyopathy, Stomatitis
This Neuropathy Peripheral side effect was reported by a physician from Japan. A female patient (weight:NA) experienced the following symptoms/conditions: prophylaxis against gastrointestinal ulcer,breast cancer metastatic,breast cancer recurrent.The patient was prescribed Mucosta (drug dosage: NA), which was initiated on
Mar 26, 2012. Concurrently used drugs:
  • Taxol
  • Avastin
.After starting to take Mucosta the consumer reported adverse symptoms, such as: Neuropathy Peripheral, Cardiac Failure Congestive, Cardiomyopathy, StomatitisThese side effects may potentially be related to Mucosta. The patient was hospitalized.
Mucosta Side Effect Report#8448448-2
Thrombocytopenia, Haemorrhagic Diathesis, Coagulopathy, Pneumonia Aspiration, White Blood Cell Count Decreased, Beta 2 Microglobulin Increased, Brain Midline Shift, Histology Abnormal, Diffuse Large B-cell Lymphoma
This is a report of a male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Mucosta (dosage: NA, start time:
Feb 26, 2008), combined with:
  • Lendormin
  • Clarithromycin
  • Diazepam
  • Sodium Chloride
  • Sennoside
  • Omeprazole
  • Onealfa
  • Solu-medrol
and developed a serious reaction and side effect(s): Thrombocytopenia, Haemorrhagic Diathesis, Coagulopathy, Pneumonia Aspiration, White Blood Cell Count Decreased, Beta 2 Microglobulin Increased, Brain Midline Shift, Histology Abnormal, Diffuse Large B-cell Lymphoma after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosta treatment in male patients, resulting in Thrombocytopenia side effect. The patient was hospitalized.
Mucosta Side Effect Report#8447197
Platelet Count Increased, Hyperkalaemia, White Blood Cell Count Increased
This report suggests a potential Mucosta Platelet Count Increased side effect(s) that can have serious consequences. A 61-year-old male patient (weight: NA) from JP was diagnosed with the following symptoms/conditions: NA and used Mucosta (dosage: 100 Mg, Uid/qd) starting
Feb 20, 2012. After starting Mucosta the patient began experiencing various side effects, including: Platelet Count Increased, Hyperkalaemia, White Blood Cell Count IncreasedAdditional drugs used concurrently:
  • Methycobal (500 Ug, Uid/qd)
  • Gasmotin (5 Mg, Uid/qd)
  • Magmitt (250 Mg, Uid/qd)
  • Berizym (1 Df, Uid/qd)
  • Seven E.p (1 Df, Uid/qd)
  • Strocain (5 Mg, Uid/qd)
  • Januvia (25 Mg, Uid/qd)
  • Amaryl (1 Mg, Uid/qd)
The patient was hospitalized. Although Mucosta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Platelet Count Increased, may still occur.
Mucosta Side Effect Report#8439663-2
Dyspnoea Exertional, Interstitial Lung Disease, Oedema, Decreased Appetite, Platelet Count Decreased, Blood Creatinine Increased, Blood Uric Acid Increased
This Dyspnoea Exertional problem was reported by a physician from Japan. A 65-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Mar 13, 2012 this consumer started treatment with Mucosta (dosage: NA). The following drugs were being taken at the same time:
  • Peg-intron (1.5 Mcg, Kg, Qw, Sc)
  • Telavic (antiviral Nos) (750 Mg, Tid, Po)
  • Ribavirin
  • Aldactone
  • Celestamine Tab
  • Interferon
  • Omeprazole
  • Sucralfate
When using Mucosta, the patient experienced the following unwanted symptoms/side effects: Dyspnoea Exertional, Interstitial Lung Disease, Oedema, Decreased Appetite, Platelet Count Decreased, Blood Creatinine Increased, Blood Uric Acid IncreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dyspnoea Exertional, may become evident only after a product is in use by the general population.
Mucosta Side Effect Report#8438349-8
Insomnia, Headache, Rhinitis Allergic, Neutrophil Count Increased, Myocardial Infarction
This Insomnia side effect was reported by a physician from Japan. A 50-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Mucosta (drug dosage: Unk), which was initiated on
Aug 27, 2011. Concurrently used drugs:
  • Pursennid
  • Lansoprazole
  • Rozerem (Unk)
  • Romiplostim - Khk (3.57 Mug/kg, Qwk)
  • Lendormin
  • Prednisolone (11 Mg, Unk)
  • Alendronate Sodium (5 Mg, Unk)
  • Acetaminophen
.After starting to take Mucosta the consumer reported adverse symptoms, such as: Insomnia, Headache, Rhinitis Allergic, Neutrophil Count Increased, Myocardial InfarctionThese side effects may potentially be related to Mucosta. The patient was hospitalized.
Mucosta Side Effect Report#8435894-6
Diabetes Mellitus Inadequate Control
This is a report of a 68-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Mucosta (dosage: NA, start time: NS), combined with:
  • Omeprazole
  • Lantus
  • Novolin R
  • Taurine
  • Lasix
  • Aldactone
  • Livact
  • Lulicon
and developed a serious reaction and side effect(s): Diabetes Mellitus Inadequate Control after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosta treatment in male patients, resulting in Diabetes Mellitus Inadequate Control side effect. The patient was hospitalized.
Mucosta Side Effect Report#8429472-2
Cerebral Infarction, Dysphagia
This report suggests a potential Mucosta Cerebral Infarction side effect(s) that can have serious consequences. A 69-year-old female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Mucosta (dosage: NA) starting
Apr 02, 2012. After starting Mucosta the patient began experiencing various side effects, including: Cerebral Infarction, DysphagiaAdditional drugs used concurrently:
  • Mucosolvan
  • Theo-dur
  • Prednisolone
  • Lansoprazole
  • Magmitt
  • Tramadol Hydrochloride And Acetaminophen (3df Per Day)
Although Mucosta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Cerebral Infarction, may still occur.
Mucosta Side Effect Report#8421678-1
Pancytopenia, Interstitial Lung Disease
This Pancytopenia problem was reported by a health professional from Japan. A 64-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Feb 24, 2012 this consumer started treatment with Mucosta (dosage: NA). The following drugs were being taken at the same time:
  • Peg-intron
  • Famotidine
  • Mixed Ointment Of Myser And Salicylic Acid
  • Peg-intron
  • Telavic (telaprevir)
  • Peg-intron
  • Loxonin
  • Rebetol
When using Mucosta, the patient experienced the following unwanted symptoms/side effects: Pancytopenia, Interstitial Lung DiseaseThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pancytopenia, may become evident only after a product is in use by the general population.
Mucosta Side Effect Report#8421001-2
Thrombocytopenia, Perivascular Dermatitis, Renal Impairment, Pruritus, Purpura, Decreased Appetite, Prerenal Failure, Asthenia
This Thrombocytopenia side effect was reported by a consumer or non-health professional from Japan. A 57-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Mucosta (drug dosage: NA), which was initiated on
Feb 24, 2012. Concurrently used drugs:
  • Telavic (telaprevir)
  • Peg-intron
  • Atelec
  • Loxonin
  • Ribavirin
  • Peg-intron
  • Glycyron
  • Candesartan Cilexetil
.After starting to take Mucosta the consumer reported adverse symptoms, such as: Thrombocytopenia, Perivascular Dermatitis, Renal Impairment, Pruritus, Purpura, Decreased Appetite, Prerenal Failure, AstheniaThese side effects may potentially be related to Mucosta. The patient was hospitalized.
Mucosta Side Effect Report#8416760-9
Productive Cough, Cough, Interstitial Lung Disease
This is a report of a 69-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: gastritis,diabetes mellitus,sputum retention,nasopharyngitis, who was treated with Mucosta (dosage: NA, start time:
Feb 17, 2011), combined with:
  • Januvia
  • Mucosolvan
  • Dasen
and developed a serious reaction and side effect(s): Productive Cough, Cough, Interstitial Lung Disease after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosta treatment in female patients, resulting in Productive Cough side effect. The patient was hospitalized.
Mucosta Side Effect Report#8407133-3
Acute Myocardial Infarction, Cardiac Failure
This report suggests a potential Mucosta (rebamipide) Acute Myocardial Infarction side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Mucosta (rebamipide) (dosage: NA) starting
May 11, 2007. After starting Mucosta (rebamipide) the patient began experiencing various side effects, including: Acute Myocardial Infarction, Cardiac FailureAdditional drugs used concurrently:
  • Calblock (azelnidipine)
  • Rythmodan R (disopyramide Phosphate)
  • Alfarol (alfacalcidol)
  • Pletal (50 Mg, Tid)
  • Bufferin
  • Dorner (beraprost Sodium)
Although Mucosta (rebamipide) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Acute Myocardial Infarction, may still occur.
Mucosta Side Effect Report#8406582-7
Renal Cancer, Gastric Cancer
This Renal Cancer problem was reported by a physician from Japan. A 84-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
May 27, 2004 this consumer started treatment with Mucosta (rebamipide) (dosage: NA). The following drugs were being taken at the same time:
  • Amlodipine Besylate
  • Candesartan Cilexetil
  • Norvasc
  • Coniel (benidipine Hydrochloride)
  • Pletal (100 Mg, Bid, Oral)
When using Mucosta (rebamipide), the patient experienced the following unwanted symptoms/side effects: Renal Cancer, Gastric CancerAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Renal Cancer, may become evident only after a product is in use by the general population.
Mucosta Side Effect Report#8406545-1
Eosinophil Count Increased, Anaemia, Eosinophilic Pneumonia, Acute Myocardial Infarction, Platelet Count Decreased, Cardiac Failure Acute, Renal Failure, Condition Aggravated, Renal Artery Stenosis
This Eosinophil Count Increased side effect was reported by a physician from Japan. A 76-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Mucosta (rebamipide) Tablet (drug dosage: NA), which was initiated on
May 11, 2007. Concurrently used drugs:
  • Calblock (azelnidipine) Tablet
  • Blopress (candesartan Cilexetil) Tablet
  • Nipolazin (mequitazine) Tablet
  • Argamate (calcium Polystyrene Sulfonate) Jelly
  • Allegra (fexofenadine Hydrochloride) Tablet
  • Pletal (50 Mg, Tid, Oral)
  • Rythmodan R (disopyramide Phosphate) Tablet
  • Alfarol (alfacalcidol) Capsule
.After starting to take Mucosta (rebamipide) Tablet the consumer reported adverse symptoms, such as: Eosinophil Count Increased, Anaemia, Eosinophilic Pneumonia, Acute Myocardial Infarction, Platelet Count Decreased, Cardiac Failure Acute, Renal Failure, Condition Aggravated, Renal Artery StenosisThese side effects may potentially be related to Mucosta (rebamipide) Tablet. The patient was hospitalized.
Mucosta Side Effect Report#8403557-9
Ventricular Extrasystoles
This is a report of a 69-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Mucosta (dosage: Unk, start time:
Jan 06, 2011), combined with:
  • Novorapid (Unk)
  • Miglitol (50 Mg, 1x/day)
  • Lansoprazole (Unk)
  • Miglitol (50 Mg, 2x/day)
  • Novolin N (Unk)
  • Diovan (Unk)
  • Lipitor (Unk)
and developed a serious reaction and side effect(s): Ventricular Extrasystoles after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosta treatment in female patients, resulting in Ventricular Extrasystoles side effect.
Mucosta Side Effect Report#8402372-X
Lung Consolidation, Interstitial Lung Disease, Cardiac Failure Acute, Malaise
This report suggests a potential Mucosta (rebamipide) Tablet, 100 Mg Lung Consolidation side effect(s) that can have serious consequences. A 82-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Mucosta (rebamipide) Tablet, 100 Mg (dosage: NA) starting
Nov 17, 2008. After starting Mucosta (rebamipide) Tablet, 100 Mg the patient began experiencing various side effects, including: Lung Consolidation, Interstitial Lung Disease, Cardiac Failure Acute, MalaiseAdditional drugs used concurrently:
  • Pletal (100 Mg, Bid, Oral)
  • Magmitt (magnesium Oxide) Tablet, 330 Mg
  • Yodel-s (senna Extract) Tablet, 80 Mg
  • Aspirin
  • Prednisolone
  • Lansoprazole
  • Losartan Potassium
  • Amaryl
The patient was hospitalized. Although Mucosta (rebamipide) Tablet, 100 Mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Lung Consolidation, may still occur.
Mucosta Side Effect Report#8402321-4
Coma, Apallic Syndrome, Depressed Level Of Consciousness, Cerebral Haemorrhage, Hemiplegia, Agitation
This Coma problem was reported by a physician from Japan. A 87-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jul 17, 2003 this consumer started treatment with Mucosta (rebamipide) Tablet (dosage: NA). The following drugs were being taken at the same time:
  • Pletal (50 Mg, Bid, Oral)
When using Mucosta (rebamipide) Tablet, the patient experienced the following unwanted symptoms/side effects: Coma, Apallic Syndrome, Depressed Level Of Consciousness, Cerebral Haemorrhage, Hemiplegia, AgitationThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Coma, may become evident only after a product is in use by the general population.
Mucosta Side Effect Report#8397906-8
Liver Disorder, Pyrexia, Epidermal Necrosis, Lymphocytic Infiltration, Lymphocyte Stimulation Test Positive, Lymphadenopathy, Face Oedema, Extravasation Blood
This Liver Disorder side effect was reported by a health professional from Japan. A 59-year-old male patient (weight:NA) experienced the following symptoms/conditions: sciatica.The patient was prescribed Mucosta (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Syakuyakukanzoto
  • Tegretol
  • Voltaren
  • Rinlaxer
  • Opalmon
  • Tokishigyakukagoshuyushokyoto
  • Vitamin B12
  • Neurotropin
.After starting to take Mucosta the consumer reported adverse symptoms, such as: Liver Disorder, Pyrexia, Epidermal Necrosis, Lymphocytic Infiltration, Lymphocyte Stimulation Test Positive, Lymphadenopathy, Face Oedema, Extravasation BloodThese side effects may potentially be related to Mucosta.
Mucosta Side Effect Report#8382722-3
Haemorrhage, Melaena, Haematuria, Renal Failure Acute, Multi-organ Failure, Bacteraemia
This is a report of a male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Mucosta (dosage: NA, start time:
Mar 12, 2012), combined with:
  • Pradaxa (220 Mg)
  • Zosyn (13.5 Mg)
  • Novolin N (4 U)
  • Albuminar (100 Ml)
  • Vasoralan (80 Mg)
  • Celebrex (200 Mg)
  • Neophagen
  • Vancomycin Hydrochloride (2000 Mg)
and developed a serious reaction and side effect(s): Haemorrhage, Melaena, Haematuria, Renal Failure Acute, Multi-organ Failure, Bacteraemia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucosta treatment in male patients, resulting in Haemorrhage side effect. The patient was hospitalized.


1 of 7 


The appearance of Mucosta on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

300x250 Start Your Diet Today
These healthy diet meal plans are based on the science of what your body needs to lose fat and maintain a lifetime commitment to health. With bistroMD you will enjoy delicious recipes prepared with the right ingredients so that you can learn how to lose weight the healthy way and also rediscover the enjoyment of eating.

What are common Mucosta Side Effects for Women?

Women Side EffectsReports
Hepatic Function Abnormal 6
Cerebral Haemorrhage 5
Death 5
Liver Disorder 5
Pyrexia 5
Decreased Appetite 4
Rash 4
Anaemia 3
Atrioventricular Block Complete 3
Fall 3

What are common Mucosta Side Effects for Men?

Men Side EffectsReports
Pyrexia 10
Decreased Appetite 7
Interstitial Lung Disease 6
Liver Disorder 6
Abdominal Pain 4
Shock 4
Anaemia 3
Ascites 3
Asthenia 3
Diarrhoea 3

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Mucosta reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Mucosta Side Effects

    Did You Have a Mucosta Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Mucosta for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Mucosta Safety Alerts, Active Ingredients, Usage Information

    More About Mucosta

    Side Effects reported to FDA: 169

    Mucosta safety alerts: No

    Reported deaths: 39

    Reported hospitalizations: 95

    Latest Mucosta clinical trials